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Background: Non-specific chronic low back pain (NSCLBP) is a major health problem. Identification of subgroups
and appropriate treatment regimen was proposed as a key priority by the Cochrane Back Review Group. We
developed a multimodal treatment (MMT) for patients with moderate to severe disability and medium risk of
poor outcome. MMT includes a) neurophysiological education on the perception of pain to decrease self-limitation
due to catastrophizing believes about the nature of NSCLBP, b) sensory training of the lower trunk because these
patients predominantly show poor sensory acuity of the trunk, and c) motor training to regain definite movement
control of the trunk.
A pilot study was conducted to investigate the feasibility of MMT, prior to a larger RCT, with focus on
patients’ adherence and the evaluation of short-term effects on pain and disability of MMT when compared
to usual physiotherapy.
Method: We conducted a randomised controlled trial (RCT) in a primary care physiotherapy centre in
Switzerland. Outcome assessment was 12 weeks after baseline. Patients with NSCLBP, considerable disability
(five or more points on the Roland and Morris Disability Questionnaire (RMDQ) and medium or high risk of
poor outcome on the Keele Start Back Tool (KSBT) were randomly allocated to either MMT or usual physiotherapy
treatment (UPT) by an independent research assistant. Treatment included up to 16 sessions over 8 to 12 weeks.
Both groups were given additional home training of 10 to 30 minutes to be performed five times per week.
Adherence to treatment was evaluated in order to assess the feasibility of the treatment. Assessments were
conducted by an independent blinded person. The primary outcome was pain (NRS 0-10) and the secondary
outcome was disability (RMDQ). Between-group effects with Student’s t-test or the Mann-Whitney U test and
the standardized mean difference of the primary outcome were calculated.
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Results: Twenty-eight patients (46% male, mean age 41.5 years (SD 10.6)) were randomized to MMT (n = 14)
or UPT (n = 14). Patients’ adherence to treatment was >80% in both groups. Pain reduction (NRS; [95% CI])
was 2.14 [1.0 to 3.5] in the MMT and 0.69 [-2.0 to 2.5.] in the UPT. The between-group difference was 1.45
[0.0 to 4.0] (p = 0.03), representing a moderate effect size of 0.66 [-0.1 to 1.5]. Reduction in disability on the
RMDQ was 6.71 [4.2 to 9.3] in MMT and 4.69 [1.9 to 7.4] in UPT, with a non-significant between-group difference of 2.02
[-1.5 to 5.6] (p = 0.25). The required sample size for a RCT with six months follow-up was estimated at 170 patients.
Conclusions: MMT was found to be feasible and to significantly reduce pain in the short term when compared with
UPT. A future RCT with a six-month follow-up would require approximately 170 patients.
Trial registration: Current Controlled Trials ISRCTN66262199. Registered 8 January 2014.
Keywords: Chronic low back pain, Patient education, Sensory motor training, Physiotherapy, Randomized
controlled trialBackground
Low back pain (LBP) is a major international health
problem with a lifetime prevalence of 80–85% [1]. In
Switzerland, low back pain generates direct medical
costs of 3.4 billion Euros, corresponding to 6.7% of total
Swiss health care expenditures, and 8.4 billion Euros of
total costs per year [2]. A specific diagnosis of LBP, such
as nerve root compression, spinal stenosis and definite
instability, is only present in about 15% of cases. In the
remaining 85% of patients, LBP is non-specific [3]. Re-
search on subgroups of LBP and the evaluation of tai-
lored treatment regimens has been declared as one of
the most important future fields of research [4]. Some
studies, with specific treatments addressed at defined
subgroups, showed better results than others, where a
“one size fits all” treatment was used [5,6].
Various research groups have demonstrated the poten-
tial value of focusing on abnormal cortical processing of
the central nervous system (CNS) in patients with non-
specific chronic low back pain (NSCLBP) [7-14]: abnor-
mal cortical processing includes cognitive, sensory and
motor disturbances.
One trial, in which neurophysiological education was
applied to patients with NSCLBP, showed a significant
change (p < 0.05) in catastrophizing beliefs about pain or
injury and in inappropriate coping strategies, measured
with the pain catastrophizing scale (PCS) [10]. This indi-
cates that a cognitive approach may play an important
role in the treatment of NSCLBP and explains why our
multimodal treatment (MMT) includes education on the
neurophysiology of pain.
Flor et al. applied two-point-discrimination (TPD), or
graphaesthesia-training, on patients with phantom limb
pain (amputees). This led to a significant reversal in ab-
normal cortical processing, shown by functional mag-
netic resonance imaging (fMRI), and a reduction in
phantom limb pain (p = 0.002), positively associated withimproved sensory discrimination ability [13]. This effect
has not yet been seen in patients with NSCLBP. Never-
theless, research has shown exceeded patterns of acti-
vation in the primary somatosensory cortex, elicited
through the application of subcutaneous electric stim-
uli to the lower back, which correlated with the severity
of chronicity in patients with NSCLBP (r = 0.74) [8]. This
suggests that central sensory changes play a role in
NSCLBP and that TPD training may reverse it. This
is the reason the decision was made to integrate TPD
training into MMT.
Processing in the motor cortex was extensively exceeded
in patients with phantom limb pain, shown on fMRI. It
was reversed (less diffuse, more confined) after six ses-
sions of imagined movement and showed significant pain
reduction (p = 0.0005) [14]. Moseley et al. found distorted
body image and tactile function in patients with LBP [11],
plus delayed recognition of right or left hand in patients
suffering from chronic regional pain syndrome (CRPS)
[15]. Delayed activation of the deep trunk-stabilizing
muscles in motor tasks [16,17] and poor movement con-
trol of the lumbar spine [18,19] are other motor aspects
associated with NSCLBP. These impairments are thought
to be caused by abnormal processing in the motor cortex.
MMT therefore includes exercises on imagined move-
ment, selective activation of deep trunk muscles and rec-
ognition training using pictures of the trunk at different
angles.
To our knowledge, a multimodal approach including
patient education and sensorimotor retraining has been
described only in a small exploratory study (n = 3) [20].
Randomized controlled trials (RCT) with a longer term
follow-up are required to evaluate the effect of MMT.
However, since the feasibility of MMT is currently un-
known, it is valuable to evaluate the short-term effects
in a pilot study, prior to conducting a larger RCT with
a longer term follow-up. For the evaluation of the theoretical
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mentation of the multimodal treatment into a study de-
sign where the effect of the programme and also the
feasibility of the study process can be assessed, we draw
valuable advice from the MRC framework for the develop-
ment of complex interventions [21].Objective
This pilot study was designed to investigate the short-
term effects of multimodal treatment on pain and dis-
ability in a clinical subgroup of patients with NSCLBP.
Adherence to treatment was evaluated to provide an as-
sessment of the treatment feasibility. Results were used
to estimate the required sample size for a larger RCT to
evaluate longer term effects.Method
Study design
This was a single-centre, assessor-blinded RCT carried out
at the medbase centre for health care in Saint Gallen,
Switzerland. Assessments were performed at baseline be-
fore first treatment and 12 weeks after baseline. Following
inclusion, written informed consent and baseline assess-
ment, patients with NSCLBP were randomly allocated to
either the multimodal treatment group (MMT) or usual
physiotherapy treatment group (UPT). Randomization of
the pre-defined number of 28 patients was concealed,
using a randomization list with a block size of four, which
was generated electronically before start of the trial. Pa-
tients were treated by two independent physiotherapists,
one in the MMT group and the other in the UPT group.
The follow up assessments were conducted by an inde-
pendent physiotherapist blinded to the group assignment.
Treatment was free of charge for all patients participating
in the study. The trial was approved by the local ethics
committee (ethics committee of the canton Saint Gallen,
Switzerland. Ethics committee trial identification number:
EKSG 12/149/1B).Recruitment
Telephone contact was made with referring general
practitioners (GP), chiropractors and rheumatologists.
Fifteen received a 20-minute power point presentation
on the background of the trial and were supplied with flyers
outlining the study. In addition, human resources managers
of local companies were contacted and requested to distrib-
ute information to their employees. Patient recruitment
was also achieved through advertisements in a local news-
paper. Interested participants were referred to an online
questionnaire for a first eligibility check. Suitable can-
didates were then contacted and invited for a final eligi-
bility check, informed consent and baseline assessment.Study population
The inclusion criteria were designed to recruit patients
with moderate to severe disability and pain and were in
accordance with the definition in the European guide-
lines for the management of NSCLBP [4]. Eligible were:
men and women aged 18 to 60 years; a LBP history of
three months or more; at least moderate disability, i.e.
five points or more on the RMDQ [22,23]; and medium
or high risk of poor outcome, as evaluated with the
Keele Start Back Tool (KSBT) [24]. Participants were ex-
cluded when they had nerve root pain, a diagnosed spe-
cific spinal pathology (such as malignancy, fracture,
infection, or inflammatory joint or bone disease), were
pregnant or less than 6 months postpartum, had a coex-
isting major medical disease causing a relative or abso-
lute contraindication to general exercise, had undergone
spinal surgery within the preceding two years, or had
had an intra-articular or perineural steroid injection on
the lumbar spine during the previous five months. Par-
ticipants had to be able to speak and read German, have a
person available to assist them with home training, have
access to the internet and consent to a time expenditure
of 30 minutes, five times per week for eight weeks, to per-
form a home programme and one/two 30-minute physio-
therapy sessions per week.
Treatment dosage
Physiotherapy treatment dosage in both groups was one
or two sessions per week during the 8 week programme,
with a maximum of 16 sessions. Patients were given
home assignments to be performed for 30 minutes five
days per week. An extension to a maximum of twelve
weeks was allowed to account for discontinuity, such as
holiday or other time issues.
Home training
Patients from both groups had personalized access to a
web-based home training interface (HTI) to guide the
home assignments. The HTI recorded adherence to as-
signments and allowed evaluation of performance (further
details outlined in the treatment paragraphs below).
Multimodal treatment group
MMT included: 1. Education on the neurophysiology of
pain; 2. Sensory retraining; and 3. Motor retraining. Treat-
ment was aimed at reducing pain and disability and, poten-
tially, addressing associated abnormal cortical processing
in NSCLBP. Additional file 1 provides a detailed time
schedule of each part of the MMT.
1. Patient education on the neurophysiology of pain
was aimed at the reduction of patients’ perception of
pain and disability, a reconsideration of protective
behaviour and self-limitation resulting from fear of
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and positive perspective of their abilities and
acknowledgment of the beneficial value of activity.
The content of this section was based on a RCT
by Moseley et al. that demonstrated a beneficial
effect of intensive neurophysiological education in
patients with NSCLBP [11]. Our education began
with an outline of a bio-psychosocial model of
LBP, including cortical dysfunction in pain and
body perception. Emphasis was placed on how this
model might explain the features of the participants’
LBP experiences. Between two and four education
sessions were held. Patients received a copy of the
book “Explain Pain” (German translation) [25]. During
the first two weeks, patients were required to read ten
pages of the book each day and, using the HTI, answer
18 relevant questions on each section.
2. The aim of the sensory retraining section was to
restore discriminate sensory acuity of the lower
back and, potentially, to restore normal cortical
processing in the sensory cortex, as Flor et al. have
shown in patients with phantom limb pain [26].
Depending on the patients’ baseline lower back
TPD-threshold, each received a set of gauges (like
tracing papers) with 16 to 20 numbered dots with
equal inter-punctual distance. Patients then had to
transfer their appropriate gauge inter-punctual value
to a Sensory Retraining Tool (SRT) integrated into
their HTI (Figure 1). Each patient had an aid person
to hold the gauge onto the patient’s back, to plot the
dots through the paper, to number them and press
the start button on the SRT. The SRT displayed dot
numbers in randomized order and the aid had toFigure 1 Sensory Retraining Tool on the home training Interface for the
patient’s back. The specifications of the gauge (16 dots, 65 millimetres inter-pu
SRT ready to start.press the relevant dot onto the patient’s back with a
pencil, so that the patient could discern and identify
the number of the dot being stimulated (Figure 2).
The answer was confirmed with true or false on
the SRT. When performance reached 80% correct
answers, treatment progressed to the next gauge
with an inter-punctual distance of five millimetres
smaller. Likewise, letters and three-letter words were
written directly onto the back. Tactile acuity was
shown to be reduced in patients with LBP and
correlated with movement control impairment [27].
A similar treatment was described by Wand et al. in
a multi-baseline study reducing pain and disability in
patients with NSCLBP [20].
3. The goal of the motor retraining was to improve
movement control of the lower back [28]. Patients
performed laterality recognition training. They were
shown photographs of a human trunk rotated or
side-bent to right or left. Patients had to determine
the perspective of the picture as quickly as possible,
using the computer programme Recognise® [29]
linked to the HTI. In a next step, patients observed
videos showing movements of increasing difficulty.
The movements then had to be performed either
physically or mentally as motor imagery exercise,
depending on the patient’s pain intensity and ability.
The first level of difficulty included small lumbar
movements, such as pelvic tilting and slight
side-bending. The second level involved larger
unidirectional and combined lumbar movements.
Movement patterns which provoked LBP were
individually identified. Motor retraining exercises
were instructed using mirrors, smartphonemultimodal treatment group. Example of a gauge plotted on
nctual distance) were imputed on the SRT as visible on laptop-screen,
Figure 2 Sensory Retraining Tool on the home training Interface for the multimodal treatment group. SRT started: The patient has to
discern the pressed dot number 14. The aid person then confirms the answer with right or wrong on the SRT and the next number appears on
the screen, and so on.
Figure 3 Home training Interface of the control group. For each
exercise and time performed at home, these parameters had to be
imputed on the HTI by the patient as shown on the picture:
Number of reversals; number of sets; time required.
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the experiences and to improve positive movement.
The aim was to enable patients to transfer their
acquired knowledge to any situation in which
their LBP arose, to modulate and improve their
movement behaviour and to reduce pain.
UPT group
At the initial visit, patients were given basic patient edu-
cation on adequate behaviour when having an exacerba-
tion of LBP: a short period of protection followed, as
soon as possible, by a return to normal movement, work
and leisure activities. Further sessions addressed signs
and symptoms. Two-thirds (i.e. 20 minutes) of each ses-
sion consisted of active treatment, such as exercises for
strengthening muscles, neuro-meningeal mobilisation and
stretching muscles. A maximum of ten minutes of passive
applications per session was allowed (such as massage,
manual therapy, electrotherapy, mud packs). These activ-
ities are in accordance with the European guidelines for
the management of active rehabilitation [4]. Each patient
received instruction on the HTI to perform an individual
home exercise programme. To observe adherence to the
home programme, patients had to report their routine of
performing exercises on the HTI (Figure 3).
Outcomes
Feasibility-related outcomes were: suitability of recruit-
ment; patients’ ability to complete each part of the home
training programme; suitability of the time frame set; treat-
ment attendance; and adherence to home assignments.
The primary outcome was mean pain intensity over
the prior 7 days (NRS 0-10). Secondary outcomes weredisability, measured with the Roland and Morris Dis-
ability Questionnaire (RMDQ), and patient-specific dis-
ability, measured with the patient-specific functional scale
(PSFS), an outcome measure found to be reliable and
responsive in patients with NSCLBP [30]. Fear avoid-
ance beliefs were measured using the fear avoidance
beliefs questionnaire FABQ [31,32] and catastrophiz-
ing thoughts with the pain catastrophizing scale PCS
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sured by means of six movement control tests, with estab-
lished validity and reliability [18,19], and sensory acuity of
the lower back by measuring the TPD threshold [35]. Sick
leave and analgesic intake during the last seven days were
recorded at both assessments.
Statistics
Treatment feasibility was defined as 80% patient partici-
pation over the complete programme (i.e. 8 to 12 weeks)
and completion of at least 80% of each part of the home
training assignments. For MMT, we aimed at ≥ 80% cor-
rect answers to the questions related to the lessons in the
book “Explain Pain”; ≥ 80% of the required quota of 10 ×Figure 4 Patient flow diagram. CONSORT 2010 Flow Diagram.60 images on recognition training using the Recognise®
software; ≥ 80% completion of the required quota of 55
sets of sensory training with the SRT. Time and frequency
spent on the movement control retraining exercises were
recorded. For UPT, we aimed at ≥ 80% compliance with
the 40 home training assignments. Satisfaction with treat-
ment was evaluated in both groups. Patients were asked
to rate whether the contents of each section were helpful
using a five point Likert scale, ranging from “strongly
agree” to “strongly disagree”.
Outcome analysis was by “intention to treat”. The re-
sults of patients fulfilling the before-mentioned require-
ments for treatment adherence were analysed in the per
protocol analysis.
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the primary and secondary outcomes. We used a two-
tailed Student’s t-test for data showing normal distribu-
tion, which was tested with the SHAPIRO-Wilks test,
and a two-tailed Mann Whitney U test where data were
not normally distributed. Results were analysed with
SPSS 20. Confidence intervals for the median difference
(e.g. for the Mann Whitney U test) were calculated with
the software r, version 3.1.1 using the Hodges-Lehman
test.
Results
Study population
Figure 4 shows the participant flow. All baseline charac-
teristics, except gender and pain catastrophizing (PCS),
were comparable (Table 1). One patient in the UPT group
dropped out (treatment attendance stopped and not con-
tactable by phone or email). The missing data of this
dropped out patient were ignored and not statistically
substituted (as this would have narrowed the CI what
would have increased the chance at type 1 error). All other
outcome data were complete (MMT n = 14, UPT n = 13).
Feasibility
Recruitment
The time span required to recruit the 28 patients was
seven months (October 2012 to May 2013). Inclusion
criteria excluded 90% of all persons interested in study
participation. Thirty-six of the 372 interested persons
met the inclusion criteria. Twenty-eight gave written in-
formed consent and were assigned either to the MMT
(n = 14) or UPT (n = 14). Additional files 2 and 3 provideTable 1 Study population, baseline characteristics
Age, mean (SD)
Gender: female (%)
Pain NRS, mean (SD)
Disability PSFS, mean (SD)
Disability RMDQ, mean (SD)
Fear avoidance beliefs FABQ, mean (SD)
Pain catastrophizing PCS, mean (SD)
Sensory acuity TPD, mean (SD)
Movement control, mean (SD) number of positive tests out of 6
Days of work lost during prior 7 days pre-therapy
Pain medication during prior 7 days
- none
- NSAID
- opioids
MMT: multimodal treatment (group); UPT: usual physiotherapy treatment (group); S
scale; RMDQ Roland and Morris Disability Questionnaire; FABQ Fear Avoidance Belie
NSAID non-steroidal anti-inflammatory drug.a detailed description of recruitment resources and the
eligibility process.
Drop-out and missing data
Six patients (three each from the MMT and UPT groups)
stopped programme attendance before completion of the
eight weeks of participation for cogent individual rea-
sons (Table 2). All patients, except one, in the UPT
attended post-therapy outcome assessment (MMT n = 14,
UPT n = 13).
Treatment frequency, time frame and home programme
adherence (per protocol analysis)
A per protocol analysis (MMT n = 11, UPT n = 11) was
conducted because inclusion of the six drop-out pa-
tients’ data would have confounded the outcomes. Treat-
ment was found to be feasible. The pre-defined level of
treatment adherence was reached: in each group more
than 80% adhered to the minimum performance of ≥80%
of each section of the assigned home programme (Table 3).
Treatment frequency for MMT was mean 8.6 (SD 2.1)
and for UPT 8.0 (SD 1.8) sessions. The programme was
carried out within the pre-determined timeframe of eight
to twelve weeks (mean MMT 9.6, UPT 9.9).
Patients’ satisfaction with treatment was sufficient and
comparable in both groups, although the time spent on
sensory retraining in the MMT group was experienced as
too long by some patients (see Additional files 4 and 5).
Treatment outcome
Table 4 shows that mean pain over the prior week de-
creased significantly more in the intervention group,MMT (n = 14) UPT (n = 14)
41.57 (9.77) 41.71 (12.21)
9 (64.3%) 6 (42.9%)
4.86 (1.61) 4.64 (1.82)
5.43 (1.58) 5.48 (1.25)
10.21 (4.44) 11.21 (3.95)
23.93 (11.58) 25.92 (12.28)
14.43 (7.62) 20.08 (8.24)
70.71 (14.39) 70.71 (14.12)
2.64 (1.55) 2.50 (1.09)
None None
7 8
5 5
2 1
D standard deviation; NRS numeric rating scale; PSFS patient-specific functional
fs Questionnaire; PCS Pain Catastrophizing Scale; TPD two-point-discrimination;
Table 2 Individual reasons for stopping programme participation
Multimodal treatment group Usual physiotherapy treatment group
1 no aid for home training (week 7) 1 exacerbation of pain (week 4)
1 problems with the home training interface (week 4) 1 no time for the home training (week 4)
1 inappropriate and misleading use of the home training interface (week 4) 1 stopped treatment, reason unknown (week 7)
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4.0] (p = 0.03), resulting in a moderate effect size of 0.66
[95% CI -0.1 to 1.5]. No significant difference between
groups was found for disability (RMDQ and PSFS),
fear avoidance beliefs (FABQ) or pain catastrophizing
(PCS). Sensory acuity of the lower back (TPD thresh-
old) showed a significant mean between-group difference
in favour of MMT (p = 0.02). Movement control remained
unchanged. Sick leave did not occur at any point.
Discussion
Feasibility
Recruitment and programme adherence
The recruitment rate was lower than expected, with 90% of
interested persons excluded. However, the target group of
patients with considerable pain (5 on the NRS) and disabil-
ity (10 points on the RMDQ) could be recruited. The strin-
gent admission criteria may have contributed to the good
patient compliance rate and positive short-term outcome.
Programme adherence was similarly satisfying in both
groups. Cogent individual reasons led to two withdrawals
of participants in the MMT: in one case, the patient’s aid
person withdrew; in the other case, the patient was irri-
tated by the fact that the HTI had difficulty in running on
his Samsung tablet (although the system was updated to
run on an android device within four days, the patient had
already withdrawn). Both patients attended post-therapy
assessment. Inappropriate and misleading use of the home
training on the HTI was observed in one patient in theTable 3 Home training assignments; patients’ adherence and
MMT assignment MMT performan
Neurophysiological education: answering 184 questions in
ten home assignments
81% (9/11) answ
Recognise® Software: determination of perspective of
10 × 60 pictures of the back.
81% (9/11) deter
Sensory retraining with 55 sets of stimuli (pressed points,
letters and 3-letter-words)
81% (9/11) fulfill
Motor retraining exercises 81% (9/11) repor
Motor retraining exercise performance per day
Frequency/day (mean, SD) 2.44 (0.81)
Minutes/day (mean, SD) 11.68 (3.17)
UPT assignment Eleven patients
Individually assigned exercises, performance reported
on the HTI
91% (10/11) repo
MMT multimodal treatment (group); UPT usual physiotherapy treatment (group).multimodal treatment group, leading to termination of
treatment. This person also attended post-therapy assess-
ment. The time spent on the home programme was re-
corded by the HTI, which was considered more accurate
and valid than self-reporting.
Cogent individual reasons also led to two withdrawals
from the UPT: one person was forced to stop because of
pain exacerbation and another person could not afford
the time required for home training. We found no exact
data indicating how many NSCLBP patients showed ex-
acerbation of pain during usual physiotherapy care treat-
ment. Only one participant had no time to exercise,
indicating high adherence to our home programme
compared with the 70% of non-engagement in given
home exercises prescribed by physiotherapists to pa-
tients with CLBP, as reported in a systematic review
[36]. Programme attendance in our study was consistent
with other studies in the field of NSCLBP, showing attri-
tion rates ranging from 10 – 42% [37-39]).
Treatment frequency and time frame
The mean number of 8.5 treatment sessions was below
the assumed average of 12 sessions, and therefore well
in line with usual prescriptions in NSCLBP. Unfortu-
nately, statistical data on the number of physiotherapy
sessions for patients with NSCLBP are not available for
comparison. It was feasible to perform the treatment
programme within 12 weeks, comparable with 10 weeks
in the study by Wand et al. [20]).performance
ce (patients participating on the complete MMT programme (n = 11))
ered >80% of the questions correctly
mined >80% of the pictures correctly
ed >80%
ted performing exercises five times a week
participated on the complete UPT programme (n = 11)
rted performance five times a week
Table 4 Treatment outcomes
Within-group mean difference [95% CI] * Between-group mean difference
[95% CI], (p-value 2-tailed)MMT n = 14 UPT n = 13
Primary outcome
Pain NRS 2.14 [1.0 to 3.5] 0.69 [-2.0 to 2.5.] 1.45 [0.0 to 4.0] (p = 0.03)
Secondary outcomes
Disability PSFS 2.55 [1.3 to 3.8] 1.13 [-0.1 to 2.4] 1.42 [-0.25 to 3.09] (p = 0.09)
Disability RMDQ 6.71 [4.2 to 9.3] 4.69 [1.9 to 7.4] 2.02 [-1.5 to 5.6] (p = 0.25)
Fear avoidance beliefs FABQ 4.79 [0.6 to 8.9] 3.85 [-2.8 to 10.5] 0.94 [-6.3 to 8.2] (p = 0.79)
Pain catastrophizing PCS 3.43 [0.1 to 6.7] 6.15 [0.2 to 12.1] -2.73 [-9.3 to 3.8] (p = 0.40)
Sensory acuity TPD 11.79 [6.8 to 16.8] -2.69 [-14.3 to 8.9] 14.48 [2.2 to 26.8] (p = 0.02)
Movement control, positive out of 6 tests -0.29 [-2 to 1] -0.69 [-1.5 to 0.0] 0.50 [-1.0 to 2.0] (p = 0.29)
Pain medication during prior 7 days 13 11
- none 2
- NSAID 1 0
- opioids 1 missing data
MMT multimodal treatment (group); UPT usual physiotherapy treatment (group); *[95% CI] 95 percent confidence interval for normal distributed data; p-value;
NRS numeric rating scale; PSFS patient-specific functional scale; RMDQ Roland and Morris Disability Questionnaire; FABQ Fear Avoidance Beliefs Questionnaire;
PCS Pain Catastrophizing Scale; TPD two-point-discrimination; NSAID non-steroidal anti-inflammatory drug.
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The 1.45 point between-group difference in pain was
smaller than the minimally clinical important difference
of 1.7, as stated in the IMMPACT recommendations by
Dworkin et al. In the same publication, the IMMPACT
recommendations suggest that the minimally clinical im-
portant difference between groups is smaller than that in
an individual patient. Between-group changes on a 1 to
10 scale ranged from 0.9 to 1.5 in nine drug studies con-
cerning pain relief in patients with knee osteoarthritis,
reviewed by Dworkin et al. [40].
The negative outcome regarding pain catastrophizing
(PCS) was unexpected; the more so since pain was sig-
nificantly reduced in the MMT group. Moseley et al.
showed a significant decrease in catastrophizing beliefs
on the PCS after intensive neurophysiology education on
pain in patients with NSCLBP [10]. Pain catastrophizing
might be further reduced by prolongation of the educa-
tion, treatment and home assignments.
TPD threshold in our patients was 70 mm (SD14),
which is slightly higher than in a previous study in a popu-
lation with NSCLBP that reported 61 mm (SD 13) [27].
Sensory acuity increased only in the MMT and is, there-
fore, likely to be the result of the sensory retraining.
Movement control decreased slightly in both groups, but
more clearly in the UPT group. This might be explained by
the fact that, due to restricted resources, baseline assess-
ment and post-treatment assessment were performed by
different assessors, with the post-treatment assessor rating
more conservatively. In future research, baseline and post-
treatment tests for MCI should be rated by an independent
blinded assessor using video recordings.Strengths
The study showed that this particular population of
NSCLBP patients was able to participate in a multimodal
treatment (intervention group) or a usual physiother-
apy treatment (UPT group) and report their performed
home training on a personal web interface. Our study
shows that ≥ 80% of patients engaged in at least 80% of
the requested home exercises, apart from those with co-
gent individual reasons for withdrawal from programme
participation. This RCT including 28 patients demon-
strates the pain reduction potential of the MMT.
Limitations
The outcomes of this study have to be interpreted with
caution because of the small sample size, as there is evi-
dence that the risk of a type 1 error is larger in small
sample sizes [39,41]. We used a pre-defined convenient
sample size of n = 28 on the assumption that this data
would give us enough information to ascertain the feasi-
bility of a larger RCT.
Differences between groups for disability on the
RMDQ, as well as on the PSFS, were not significant. The
small between-group difference in change on fear avoid-
ance beliefs (FABQ) may be explained by low responsive-
ness of the FABQ identified in a review [42]. We chose to
apply this measure nevertheless since it had been validated
in NSCLBP-populations and found to be a reliable and
commonly-used measure of cognitive aspects of pain and
function [41]. Another limitation is that patients recruited
by advertisement may be different from those referred
by physicians. However, the same inclusion criteria
were used for all patients and randomization divided
Wälti et al. BMC Musculoskeletal Disorders  (2015) 16:83 Page 10 of 11patients from both recruitment sources equally over
both treatment groups.
Our assumptions on changes to the central nervous
system were based on studies with comparable, but not
identical, diagnoses. Based on these assumptions, we de-
signed a treatment targeting three topics: education, sen-
sory system and motor system. The question of causative
relationship between NSCLBP and changes in the central
nervous system would require functional imaging to
evaluate changes in the central nervous system.
Clinical applicability
To our knowledge, this is the first study in a NSCLBP
population to use the internet for treatment and require
an aid person for home exercises. These requirements
reduce its general applicability in physiotherapy. Within
the next ten years, a rapid increase in the use of technol-
ogy is expected and technical solutions may be devel-
oped to enable independent exercise.
Sample size of a RCT to evaluate long term results
Our results allow cautious sample size estimation for a
study with a six-month follow-up. In the present study,
the true mean between-group difference was 1.45 and the
pooled standard deviation 2.11. Based on the assumption
of a smaller true mean between-group difference in favour
of MMT of 1.0 NRS point and a SD of 2.2. at six months,
a power of 0.8 and a Type I error probability of 0.05 and
accounting for 10% drop-outs, a total of 170 patients
would be needed (g power software version 3.1.7 [43]).
Conclusion
Both treatment programmes were feasible. Patients in
both treatment groups showed good adherence both to
treatment sessions and home assignments. Although the
size of the effect was moderate, multimodal treatment
reduced pain compared with usual physiotherapy. The
results must be interpreted with caution because of the
small sample size. MMT focussed on cognitive aspects
concerning pain, sensory acuity of the lower back, move-
ment control and body-awareness in daily living.
The multimodal treatment approach seems to be a po-
tential alternative to conventional physiotherapy treat-
ment. Based on our results, we estimate that 170 patients
are needed to evaluate the six months’ effects. To increase
the recruitment rate from approximately 50 to 200 eligible
participants per year the study will be conducted in four
centres.Additional files
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Additional file 3: Online eligibility testing.
Additional file 4: MMT Patients satisfaction with treatment.
Additional file 5: UPT Patients satisfaction with treatment.
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